Molybdenum(IV) sulphide, min. 98%, pure, 500 g, plastic packaging.

Tris(3-chlorophenyl)phosphine, 97%, 1g

1,3-Dimethyl-1H-pyrazol-5-amine>98.0%(GC)5g

Ethyl 1-N-Cbz-4-oxo-pyrrolidine-3-carboxylate, 95.0%, 5g

Pouring mouth, DIN 61, 2 pieces

[1,1:2,1-Terphenyl]-4,4-dicarboxaldehyde, 4,5-bis(4-formylphenyl)-, 98.0%, 100mg

2-Methyltetrahydrofuran (stabilised with BHT), 99.0%, 25ml

GC capillary column ROTI®Cap-FFAP, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

(S)-2-Allyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

5-Bromo-2-isopropoxythiazole, 95.0%, 250mg

3-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidine, 95%, 250mg

N-[4-(methylthio)benzyl]-2-propen-1-amine hydrochloride, 95.0%, 1g

4-Bromo-2-methoxypyridine, 99.00%, 5g